权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Project 3: Control of Differentiation and Dedifferentiation in Human Development

项目3：控制人类发展的分化和去分化

基本信息

批准号：
8382274
负责人：
William E Lowry
金额：
$ 33.92万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-08-01 至 2016-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8382274
关键词：
Adult Animal Experimentation Automobile Driving Bioinformatics Caenorhabditis elegans Cell Fate Control Cells Cellular biology Collaborations Core Facility Data Development Disease Disease model Embryo Epigenetic Process Family member Fetal Development Gene Expression Generations Genes Germ Layers Human Human Development In Vitro Knowledge Lead Life Malignant Neoplasms Mediator of activation protein Methods MicroRNAs Modification Molecular Pathway interactions Patients Play Pluripotent Stem Cells Pregnancy Process Publishing RNA Sequences Regenerative Medicine Regulation Reporter Role Screening procedure Somatic Cell Staging Stem cells Tissues Transplantation Work base cell type clinical application clinically relevant cohort early embryonic stage fetal genome-wide histone modification human embryonic stem cell human subject human tissue improved in vivo induced pluripotent stem cell inhibitor/antagonist loss of function model development novel pluripotency small molecule stem cell biology tool tumorigenesis

项目摘要

The promise of stem cell biology is predicated on the idea that these cells will be utilized in regenerative medicine and to model development and disease of tissues in vitro. While fantastic progress has been made in the generation of patient-specific stem cells through the use of reprogramming of somatic cells to a pluripotent state, little is known about the basic biology of these cells and whether they will be able to live up to their promise in regenerative medicine, development and disease. We have found that in vitro differentiation from hESCs and hiPSCs does not accurately reflect in vivo differentiation in human tissue. We have identified a molecular basis for this discrepancy and preliminary data suggest that in fact differentiation from human pluripotent stem cells could reflect human development but from a very early embryonic stage. We identified LIN28/let-7 as able to control human differentiation during early fetal development, in congruence with what has been shown for this circuit in C. Elegans. We propose to manipulate this important gene expression circuit to determine whether proper control of this circuit is vital to allow for maturation of human cells. This project will also develop tools that will allow for manipulation of this circuit and a simplified method for driving cellular maturation in vitro. Finally, we will use genome-wide approaches to understand how this circuit is normally regulated and whether it is representative of a cohort of co-regulated genes important for human development. This project will significantly contribute to our limited knowledge of human development, and the control of cell fate with human pluripotent stem cells. There will be no human subjects or animal experimentation with the proposed work.

干细胞生物学的前景是基于这样一个想法，即这些细胞将被用于再生医学，并在体外模拟组织的发育和疾病。虽然通过将体细胞重新编程为多能状态，在生成针对患者的干细胞方面取得了惊人的进展，但人们对这些细胞的基本生物学以及它们是否能够在再生医学、发育和疾病方面实现承诺知之甚少。我们发现，hESCs和hiPSCs的体外分化并不能准确地反映人体组织的体内分化。我们已经确定了这种差异的分子基础，初步数据表明，事实上，从人类多能干细胞分化可以反映人类的发育，但从非常早期的胚胎阶段开始。我们发现LIN28/LET-7能够在早期胎儿发育中控制人类的分化，这与线虫的这一回路显示的一致。我们建议操纵这一重要的基因表达回路，以确定对这一回路的适当控制是否对人类细胞的成熟至关重要。该项目还将开发工具，以允许操纵这一电路和一种简化的方法，以推动细胞在体外成熟。最后，我们将使用全基因组的方法来了解这一回路是如何正常调节的，以及它是否代表了一组对人类发育重要的共同调节基因。这个项目将大大有助于我们对人类发育的有限了解，以及对人类多能干细胞细胞命运的控制。这项拟议的工作将不会进行人体或动物实验。